Protagonist Therapeutics, Inc. (PTGX)
86.74
-1.19
(-1.35%)
USD |
NASDAQ |
Dec 30, 11:31
Protagonist Therapeutics Research and Development Expense (Quarterly): 40.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.693B |
| ADMA Biologics, Inc. | 1.528M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Bristol Myers Squibb Co. | 2.433B |
| MannKind Corp. | 14.06M |